Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
AdipoGen Life Sciences
Vincristine . sulfate
55
CHF
CHF 55.00
In stock
AG-CN2-0446-M0055 mgCHF 55.00
AG-CN2-0446-M02525 mgCHF 180.00
| Product Details | |
|---|---|
| Synonyms | VCR; 22-Oxovincaleukoblastine; NSC 67574; Oncovin; Lilly 37231; Leucristine; Leurocristine; LS-228 |
| Product Type | Chemical |
| Properties | |
| Formula |
C46H56N4O10 . H2SO4 |
| MW | 825.0 . 98.1 |
| Merck Index | 14: 9986 |
| CAS | 2068-78-2 |
| RTECS | OH6340000 |
| Source/Host Chemicals | Synthetic. Originally isolated from Vinca rosea. |
| Purity Chemicals | ≥98% (HPLC) |
| Appearance | White to light-yellow powder. |
| Solubility | Soluble in water, DMSO or methanol. |
| InChi Key | AQTQHPDCURKLKT-JKDPCDLQSA-N |
| Smiles | OS(O)(=O)=O.[H]C(=O)N1C2=C(C=C(C(OC)=C2)[C@]2(C[C@@H]3C[N@@](C[C@](O)(CC)C3)CCC3=C2NC2=C3C=CC=C2)C(=O)OC)[C@@]23CCN4CC=C[C@@](CC)([C@@H](OC(C)=O)[C@](O)(C(=O)OC)[C@]12[H])[C@@]34[H] |
| Shipping and Handling | |
| Shipping | AMBIENT |
| Short Term Storage | +20°C |
| Long Term Storage | +4°C |
| Handling Advice | Protect from light and moisture. |
| Use/Stability | Stable for at least 2 years after receipt when stored at +4°C. |
| Documents | |
| MSDS |
 Download PDF |
| Product Specification Sheet | |
| Datasheet |
Download PDF |
Description
- Immunosuppressant.
- Anticancer compound. Chemotherapeutic agent.
- Depolymerizes microtubules and irreversibly blocks binding of tubulin to microtubule proteins.
- Apoptosis inducer and cell cycle inhibitor in G2/M phase.
- Autophagy inhibitor. Inhibits microtubule-mediated fusion of autophagosome with lysosme.
- Inducer of IL-1β production.
- Activates alone and synergistically together with doxorubicin the NLRP3-inflammasome mediated processing of IL-1β.
- Monoamine oxidase (MAO) inhibitor.
Product References
- Suppression of immune response by Vincristine and Vinblastine: A.C. Aisenberg; Nature 200, 484 (1963)
- Vinblastine and vincristine are inhibitors of monoamine oxidase B: J.K. Son, et al.; J. Med. Chem. 33, 1845 (1990)
- Cell death induced by vincristine in the intestinal crypts of mice and in a human Burkitt's lymphoma cell line: B.V. Harmon, et al.; Cell Prolif. 25, 523 (1992)
- Interaction of vinca alkaloids with tubulin: a comparison of vinblastine, vincristine, and vinorelbine: S. Lobert, et al.; Biochemistry 35, 6806 (1996)
- Antimitotic natural products and their interactions with tubulin: E. Hamel; Med. Res. Rev. 16, 207 (1996)
- Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death: M.V. Blagosklonny, et al.; Cancer Res. 57, 130 (1997)
- Tubulin as a target for anticancer drugs: agents which interact with the mitotic spindle: A. Jordan, et al.; Med. Res. Rev. 18, 259 (1998) (Review)
- The effect of antimicrotubule agents on signal transduction pathways of apoptosis: a review: L.G. Wang; Cancer Chemother. Pharmacol. 44, 355 (1999) (Review)
- Vincristine-induced apoptosis in vivo in peripheral blood mononuclear cells of children with acute lymphoblastic leukaemia (ALL): E. Groninger, et al.; Br. J. Haematol. 111, 875 (2000)
- Autophagy-mediated HMGB1 release antagonizes apoptosis of gastric cancer cells induced by vincristine via transcriptional regulation of Mcl-1: Z. Zhan, et al.; Autophagy 8, 109 (2012)
- Autophagy and microtubules - new story, old players: R. Mackeh, et al.; J. Cell Sci. 126, 1071 (2013) (Review)
- Production of IL-1β by bone marrow-derived macrophages in response to chemotherapeutic drugs: synergistic effects of doxorubicin and vincristine: J. Wong, et al.; Cancer Biol. Ther. 15, 1395 (2014)
Related Products
